MEDPRIN REGENERATIMM

MEDPRIN REGENERATI

46,96CNYD
−0,27−0,57%
Alla chiusura del 21 feb, 07:55 GMT
CNY
Nessun attività
Visualizza sui grafici

Fondamentali 301033

MEDPRIN REGENERATI bilanci, compresi i ricavi, spese e i profitti

Il fatturato totale di 301033 per l'ultimo trimestre è di 67.56 M CNY, in crescita del 6.01% rispetto al trimestre precedente. L'utile netto nel Q3 24 è di 20.41 M CNY.

Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0,00‬
‪‪21,00 M‬‬
‪‪42,00 M‬‬
‪‪63,00 M‬‬
‪‪84,00 M‬‬
Fatturato totale
Utile lordo
Utile operativo
Utile lordo
Utile netto
Valuta: CNY
Q1 '21
Mar 2021
Q2 '21
Giu 2021
Q3 '21
Set 2021
Q4 '21
Dic 2021
Q1 '22
Mar 2022
Q2 '22
Giu 2022
Q3 '22
Set 2022
Q4 '22
Dic 2022
Q1 '23
Mar 2023
Q2 '23
Giu 2023
Q3 '23
Set 2023
Q4 '23
Dic 2023
Q1 '24
Mar 2024
Q2 '24
Giu 2024
Q3 '24
Set 2024
TTM
Fatturato totaleCrescita YoY
‪‪55,20 M‬‬
+9,62%
‪‪43,52 M‬‬
+16,98%
‪‪40,22 M‬‬
−29,70%
‪‪58,99 M‬‬
+35,29%
‪‪83,57 M‬‬
+51,40%
‪‪56,05 M‬‬
+28,80%
‪‪63,73 M‬‬
+58,45%
‪‪67,56 M‬‬
+14,52%
‪‪270,91 M‬‬
‪‪−14,27 M‬‬
‪‪−13,96 M‬‬
‪‪−13,95 M‬‬
‪‪−15,93 M‬‬
‪‪−19,43 M‬‬
‪‪−16,13 M‬‬
‪‪−20,53 M‬‬
‪‪−15,78 M‬‬
‪‪−71,87 M‬‬
Utile lordoCrescita YoY
‪‪40,93 M‬‬
+2,86%
‪‪29,56 M‬‬
+2,98%
‪‪26,27 M‬‬
−43,94%
‪‪43,06 M‬‬
+28,91%
‪‪64,15 M‬‬
+56,73%
‪‪39,92 M‬‬
+35,04%
‪‪43,19 M‬‬
+64,40%
‪‪51,78 M‬‬
+20,23%
‪‪219,82 M‬‬
‪‪−38,87 M‬‬
‪‪−21,82 M‬‬
‪‪−23,08 M‬‬
‪‪−27,93 M‬‬
‪‪−48,48 M‬‬
‪‪−25,60 M‬‬
‪‪−27,08 M‬‬
‪‪−31,25 M‬‬
‪‪−132,42 M‬‬
Utile operativoCrescita YoY
‪‪2,06 M‬‬
+81,39%
‪‪7,74 M‬‬
+48,56%
‪‪3,20 M‬‬
−71,80%
‪‪15,13 M‬‬
+111,74%
‪‪15,67 M‬‬
+659,13%
‪‪14,32 M‬‬
+84,92%
‪‪16,11 M‬‬
+404,16%
‪‪20,52 M‬‬
+35,62%
‪‪66,62 M‬‬
‪‪3,99 M‬‬
‪‪1,19 M‬‬
‪‪1,75 M‬‬
‪‪837,35 K‬‬
‪‪2,50 M‬‬
‪‪4,40 M‬‬
‪‪3,61 M‬‬
‪‪3,72 M‬‬
‪‪14,24 M‬‬
Utile lordoCrescita YoY
‪‪6,05 M‬‬
−57,24%
‪‪8,93 M‬‬
+6,94%
‪‪4,95 M‬‬
−68,69%
‪‪15,97 M‬‬
+63,83%
‪‪18,17 M‬‬
+200,22%
‪‪18,72 M‬‬
+109,57%
‪‪19,72 M‬‬
+298,47%
‪‪24,24 M‬‬
+51,81%
‪‪80,86 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−283,56 K‬‬
‪‪−1,12 M‬‬
‪‪−874,01 K‬‬
‪‪−2,44 M‬‬
‪‪−2,72 M‬‬
‪‪−3,78 M‬‬
‪‪−2,27 M‬‬
‪‪−3,83 M‬‬
‪‪−12,60 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪5,77 M‬‬
‪‪7,82 M‬‬
‪‪4,08 M‬‬
‪‪13,53 M‬‬
‪‪15,45 M‬‬
‪‪14,94 M‬‬
‪‪17,45 M‬‬
‪‪20,41 M‬‬
‪‪68,26 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Utile nettoCrescita YoY
‪‪5,77 M‬‬
−54,53%
‪‪7,82 M‬‬
+9,08%
‪‪4,08 M‬‬
−71,05%
‪‪13,53 M‬‬
+52,35%
‪‪15,45 M‬‬
+167,90%
‪‪14,94 M‬‬
+91,19%
‪‪17,45 M‬‬
+328,11%
‪‪20,41 M‬‬
+50,83%
‪‪68,26 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪5,77 M‬‬
‪‪7,82 M‬‬
‪‪4,08 M‬‬
‪‪13,53 M‬‬
‪‪15,45 M‬‬
‪‪14,94 M‬‬
‪‪17,45 M‬‬
‪‪20,41 M‬‬
‪‪68,26 M‬‬
‪0,09‬
−54,53%
‪0,12‬
+9,03%
‪0,06‬
−71,03%
‪0,20‬
+52,27%
‪0,23‬
+167,93%
‪0,23‬
+91,21%
‪0,27‬
+330,31%
‪0,31‬
+51,66%
‪1,04‬
‪0,09‬
−54,53%
‪0,12‬
+9,03%
‪0,06‬
−71,03%
‪0,20‬
+52,27%
‪0,23‬
+167,93%
‪0,23‬
+91,21%
‪0,27‬
+330,31%
‪0,31‬
+51,66%
‪1,04‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪65,71 M‬‬
‪‪65,71 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪66,06 M‬‬
‪‪65,71 M‬‬
‪‪65,71 M‬‬
EBITDACrescita YoY
‪‪7,27 M‬‬
+60,69%
‪‪14,11 M‬‬
+70,85%
‪‪9,56 M‬‬
−33,49%
‪‪22,04 M‬‬
+78,40%
‪‪22,57 M‬‬
+210,45%
‪‪21,26 M‬‬
+50,62%
‪‪23,05 M‬‬
+140,98%
EBITCrescita YoY
‪‪2,06 M‬‬
+81,39%
‪‪7,74 M‬‬
+48,56%
‪‪3,20 M‬‬
−71,80%
‪‪15,13 M‬‬
+111,74%
‪‪15,67 M‬‬
+659,13%
‪‪14,32 M‬‬
+84,92%
‪‪16,11 M‬‬
+404,16%
‪‪20,52 M‬‬
+35,62%
‪‪66,62 M‬‬
‪‪−53,14 M‬‬
‪‪−35,77 M‬‬
‪‪−37,02 M‬‬
‪‪−43,86 M‬‬
‪‪−67,91 M‬‬
‪‪−41,73 M‬‬
‪‪−47,61 M‬‬
‪‪−47,03 M‬‬
‪‪−204,29 M‬‬